Immunovia AB (OTCPK:IMMVF)
$ 0.07382 0 (0%) Market Cap: 8.20 Mil Enterprise Value: 3.48 Mil PE Ratio: 0 PB Ratio: 2.76 GF Score: 49/100

Q3 2024 Immunovia AB (publ) Earnings Call Transcript

Nov 27, 2024 / 02:00PM GMT
Release Date Price: $0.07382
Operator

Ladies and gentlemen, welcome to the Immunovia Q3 interim report 2024 conference call. I am Yusuf, the Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Karin Almqvist Liwendahl, CFO. Please go ahead.

Karin Liwendahl;publ;Chief Financial Officer
Immunovia AB

()-

Thank you very much. And with that, I would like to say good morning and a good afternoon, and a warm welcome to all of you joining today to Immunovia's conference call following our third quarter results for 2024.

Presenting in the call today is our CEO, Jeff Borcherding; and myself, Karin Almqvist, CFO of the company. As usual, the presentation will be followed by a Q&A session, which will be guided by our operator. You are welcome to give your questions in the call or post them via the chat function.

After we have closed today's call, you will find the presentation and a recording

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot